Health care partner Eve Brunts (Boston) and health care counsel Alison Fethke (Chicago) co-authored a July 12 Law360 expert analysis article on value-based health care challenges and opportunities for pharmaceutical companies.
The co-authors explain that new value-based pricing arrangements connecting the price of drugs to their perceived value contain challenges for pharmaceutical product developers and manufacturers. These challenges include aligning a value-based pricing arrangement with the strategic objectives of biopharmaceutical companies and appealing to purchasers, health insurance plans and other third-party payors, along with addressing legal and operations issues.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.